Medical Microbiology articles for National Institutes of Health (NIH), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 57

Article ‘Count’ for Medical Microbiology.

Journal Count Share
2 0.17
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections 0.02
Human monoclonal antibodies targeting A35 protect from death caused by mpox 0.15
1 0.01
Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential 0.01
3 0.19
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial 0.05
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C 0.11
Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus 0.04
1 0.13
Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis B 0.13
1 0.17
The RNA thermometer motif ROSE-G regulates ABC transporter gene expression in bacteria 0.17
2 0.99
HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort 0.18
Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells 0.81
2 0.53
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort 0.03
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection 0.50
10 2.62
High Seropositivity to rK39 and Capture of Leishmania-Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India 0.21
Epstein-Barr Virus Antibody Response Patterns in Endemic and Non-Endemic Cases of Nasopharyngeal Carcinoma 0.23
Immune responses to BK virus in renal transplant recipients receiving IVIG treatment 0.14
The common cold is associated with protection from SARS-CoV-2 Infections 0.05
Effectiveness of Long-Lasting Insecticide-Impregnated Bed Nets in Controlling iPhlebotomus argentipes/i in Sri Lanka: A Cluster Randomized Controlled Trial 0.38
A human monoclonal antibody targeting α-Gal ameliorates experimental cutaneous leishmaniasis 1.00
From Skin to Sequence: Pan-species Detection and Speciation of iLeishmania/i 0.20
Assessing the Potential of Sexual Transmission of Lassa Virus in a Natural Rodent Reservoir 0.20
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance 0.13
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death 0.09
1 0.15
Structural Basis for HIV-1 Maturation Inhibition by PF-46396 Determined by MAS NMR 0.15
1 0.02
SuFEx-based antitubercular compound irreversibly inhibits Pks13 0.02
17 4.24
SARS-CoV-2 infection and vaccination elicit distinct pharyngeal mucosal B cell responses in children 0.68
Nasopharyngeal carcinoma screening using Epstein–Barr virus Cp methylation triage in two population-based screening cohorts 0.07
Potent acridone antimalarial against all three life stages of Plasmodium 0.07
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants 0.08
A common DNA deletion altering the 3’UTR of is associated with reduced mefloquine susceptibility in parasites from Cambodian patients 0.13
A single valine to leucine switch disrupts Plasmodium falciparum AP2-G DNA binding and reveals GDV1’s role in ap2-g activation 0.08
CD44 cross-linking promotes Plasmodium falciparum invasion 0.25
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution 0.03
High-resolution proteomics unveils salivary gland disruption and saliva-hemolymph protein exchange in Plasmodium-infected mosquitoes 0.62
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents 0.47
Epigenetically conferred ring-stage survival in against artemisinin treatment 0.17
Worldwide genetic diversity of vivax is consistent with natural selection by anopheline mosquitoes 0.50
Using COVID-19 pandemic perturbation to model RSV-hMPV interactions and potential implications under RSV interventions 0.10
HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors 0.19
Synchronized seasonal excretion of multiple coronaviruses coincides with high rates of coinfection in immature bats 0.07
Cryo-EM structures of the Ton and Tol motor complexes 0.71
Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China 0.02
1 0.38
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans 0.38
2 0.28
Evidence of monkeypox virus clade IIb lineage A.2.2 in the Republic of the Congo and co-circulation of clade Ia, Ib and clade IIb 0.06
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis 0.22
1 0.14
Systematic identification of Salmonella T6SS effectors uncovers diverse new families and lipid-targeting activities 0.14
1 0.04
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials 0.04
3 0.55
Extensive heterozygosity and genetic exchange among natural populations of Leishmania species 0.31
Antibody responses to a highly conserved peptide in HCV E2 protein correlate with chronicity or spontaneous clearance of HCV infection 0.09
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence 0.15
1 0.12
Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families 0.12
4 2.38
The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs 0.67
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.32
PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes 0.50
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies 0.90
1 0.20
“Paraxenoviridae”, a putative family of globally distributed marine bacteriophages with double-stranded RNA genomes 0.20
1 0.41
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial 0.41
1 0.04
Tecovirimat for the Treatment of Mpox 0.04

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.